Zydus Becomes A Part Of History As It Loses On US Canagliflozin Patents
Three US Patents Not Invalid, New Jersey Court Rules
ANDA sponsor Zydus Cadila has failed to convince a US district court that three patents shielding the Invokana/Invokamet brands were invalid, as it became a little part of history in one of the major trials to be held amid the coronavirus pandemic.
